Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etanercept in adults with vitiligo
NCT00134368Phase 2Completed
- Sponsor
- University of Medicine and Dentistry of New Jersey
- Start
- Nov 2003
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of etanercept in Vitiligo, sponsored by University of Medicine and Dentistry of New Jersey. Started Nov 2003; status: completed.
02
Drugs
etanercept
03
Conditions
Vitiligo
Beyond the preview
Go deeper on NCT00134368.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00134368.